Recently, Kostyushev et al. proposed an alternative approach: instead of repressing HBV genes, they designed a dSpCas9-p300-based CRISPRa system to activate genes related to the APOBEC/AID pathway, which is a natural mechanism to suppress viral infection. The gene discussed is EP300; the disease is viral infectious disease.